SCHEMBL4717596

SCHEMBL4717596

O=S(=O)=Nc1ncco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4286663 0.71 HPGDS (0.30)
SCHEMBL1047665 0.67
SCHEMBL1047666 0.67
SCHEMBL11455275 0.67
SCHEMBL9608311 0.67
SCHEMBL2944099 0.67
SCHEMBL1259564 0.64
SCHEMBL9601119 0.62
SCHEMBL1680430 0.62
SCHEMBL21631871 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404317-B1 5-HALO-TRYPTAMINE DERIVATIVES USED AS LIGANDS OF THE 5-HT 6? AND/OR 5-HT 7? SEROTONIN RECEPTORS SIGMA TAU IND FARMACEUTI (IT) 2008-12-10 EP disclosed
US-7098233-B2 5-halo-tryptamine derivatives used as ligands on the 5-HT6 and/or 5-HT7 serotonin receptors SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2006-08-29 US disclosed
US-6875771-B2 Pyridopyrimidine derivatives as 5-HT6 antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2005-04-05 US disclosed
US-20040235899-A1 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2004-11-25 US disclosed
US-6737426-B1 SUCH AS (4-PHENYLSULFONYL-2-PYRIDIN-3-YL-OXAZOL-5-YL)-METHYLAMINE; ANTICONVULSANTS, ANTIINFLAMMATORIES, NEURO-PROTECTANTS, CEREBROPROTECTANTS, NOOTROPICS MERCK PATENT GMBH (DE) 2004-05-18 US disclosed
US-6737426-B1 SUCH AS (4-PHENYLSULFONYL-2-PYRIDIN-3-YL-OXAZOL-5-YL)-METHYLAMINE; ANTICONVULSANTS, ANTIINFLAMMATORIES, NEURO-PROTECTANTS, CEREBROPROTECTANTS, NOOTROPICS MERCK PATENT GMBH (DE) 2004-05-18 US disclosed
CN-1146549-C Sulphoneylxazolamines as therapeutic active ingredients Ĭ��ר���ɷ����޹�˾ 2004-04-21 CN disclosed
US-20040019064-A1 Pyridopyrimidine derivatives as 5-HT6 antagonists WU YONG-JIN (US) 2004-01-29 US disclosed
WO-2002100842-A1 SULFONYLOXAZOLAMINES AND THEIR USE AS 5-HT6 LIGANDS MERCK PATENT GMBH (DE) 2002-12-19 WO disclosed
WO-2002100842-A1 SULFONYLOXAZOLAMINES AND THEIR USE AS 5-HT6 LIGANDS MERCK PATENT GMBH (DE) 2002-12-19 WO disclosed
EP-1233963-A2 NOVEL SULFONYL OXAZOLE AMINES MERCK PATENT GmbH (DE) 2002-08-28 EP disclosed
US-6441013-B1 5-HT6 RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS MERCK PATENT GMBH (DE) 2002-08-27 US disclosed
US-6441013-B1 5-HT6 RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS MERCK PATENT GMBH (DE) 2002-08-27 US disclosed
US-6441013-B1 5-HT6 RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS MERCK PATENT GMBH (DE) 2002-08-27 US disclosed
CN-1331684-A Sulphoneylxazolamines as therapeutic active ingredients MERCK PATENT GMBH (DE) 2002-01-16 CN disclosed
EP-1140875-A1 SULPHONYLOXAZOLAMINES AS THERAPEUTIC ACTIVE INGREDIENTS MERCK PATENT GmbH (DE) 2001-10-10 EP disclosed
EP-1140875-A1 SULPHONYLOXAZOLAMINES AS THERAPEUTIC ACTIVE INGREDIENTS MERCK PATENT GmbH (DE) 2001-10-10 EP disclosed
WO-2001038316-A2 SULFONYL OXAZOLE AMINES AND THEIR USE AS 5-HT6 RECEPTOR LIGANDS MERCK PATENT GMBH (DE) 2001-05-31 WO disclosed
WO-2000037452-A1 SULPHONYLOXAZOLAMINES AS THERAPEUTIC ACTIVE INGREDIENTS MERCK PATENT GMBH (DE) 2000-06-29 WO disclosed
WO-2000037452-A1 SULPHONYLOXAZOLAMINES AS THERAPEUTIC ACTIVE INGREDIENTS MERCK PATENT GMBH (DE) 2000-06-29 WO disclosed